Diagnosis and Management of Obstructive Sleep Apnea A Review

被引:811
作者
Gottlieb, Daniel J. [1 ,2 ,3 ,4 ]
Punjabi, Naresh M. [5 ]
机构
[1] VA Boston Healthcare Syst, Med Serv, Boston, MA USA
[2] Brigham & Womens Hosp, Dept Med, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Neurol, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA
[4] Harvard Med Sch, Div Sleep Med, Boston, MA 02115 USA
[5] Johns Hopkins Univ, Div Pulm & Crit Care Med, Baltimore, MD USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2020年 / 323卷 / 14期
基金
美国国家卫生研究院;
关键词
POSITIVE AIRWAY PRESSURE; CLINICAL-PRACTICE GUIDELINE; BLOOD-PRESSURE; WEIGHT-LOSS; AMERICAN ACADEMY; PORTABLE SLEEP; RESISTANT HYPERTENSION; SURGICAL MODIFICATIONS; CARDIOVASCULAR EVENTS; BERLIN QUESTIONNAIRE;
D O I
10.1001/jama.2020.3514
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Importance Obstructive sleep apnea (OSA) affects 17% of women and 34% of men in the US and has a similar prevalence in other countries. This review provides an update on the diagnosis and treatment of OSA. Observations The most common presenting symptom of OSA is excessive sleepiness, although this symptom is reported by as few as 15% to 50% of people with OSA in the general population. OSA is associated with a 2- to 3-fold increased risk of cardiovascular and metabolic disease. In many patients, OSA can be diagnosed with home sleep apnea testing, which has a sensitivity of approximately 80%. Effective treatments include weight loss and exercise, positive airway pressure, oral appliances that hold the jaw forward during sleep, and surgical modification of the pharyngeal soft tissues or facial skeleton to enlarge the upper airway. Hypoglossal nerve stimulation is effective in select patients with a body mass index less than 32. There are currently no effective pharmacological therapies. Treatment with positive airway pressure lowers blood pressure, especially in patients with resistant hypertension; however, randomized clinical trials of OSA treatment have not demonstrated significant benefit on rates of cardiovascular or cerebrovascular events. Conclusions and Relevance OSA is common and the prevalence is increasing with the increased prevalence of obesity. Daytime sleepiness is among the most common symptoms, but many patients with OSA are asymptomatic. Patients with OSA who are asymptomatic, or whose symptoms are minimally bothersome and pose no apparent risk to driving safety, can be treated with behavioral measures, such as weight loss and exercise. Interventions such as positive airway pressure are recommended for those with excessive sleepiness and resistant hypertension. Managing asymptomatic OSA to reduce cardiovascular and cerebrovascular events is not currently supported by high-quality evidence. This review provides an update on the epidemiology, pathophysiology, diagnosis, and management of obstructive sleep apnea, including the incorporation of questions regarding snoring, breathing pauses at night, and excessive fatigue or sleepiness during the day at routine clinician visits and the increased use of home sleep apnea testing rather than in-hospital testing for diagnostic purposes.
引用
收藏
页码:1389 / 1400
页数:12
相关论文
共 108 条
  • [1] The prevalence of obstructive sleep apnea in patients with atrial fibrillation
    Abumuamar, Asmaa M.
    Dorian, Paul
    Newman, David
    Shapiro, Colin M.
    [J]. CLINICAL CARDIOLOGY, 2018, 41 (05) : 601 - 607
  • [2] [Anonymous], PHYS FEE SCHED SEARC
  • [3] Obstructive sleep apnoea in the general population: highly prevalent but minimal symptoms
    Arnardottir, Erna S.
    Bjornsdottir, Erla
    Olafsdottir, Kristin A.
    Benediktsdottir, Bryndis
    Gislason, Thorarinn
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (01) : 194 - 202
  • [4] Bariatric Surgery or Non-Surgical Weight Loss for Obstructive Sleep Apnoea? A Systematic Review and Comparison of Meta-analyses
    Ashrafian, Hutan
    Toma, Tania
    Rowland, Simon P.
    Harling, Leanne
    Tan, Alan
    Efthimiou, Evangelos
    Darzi, Ara
    Athanasiou, Thanos
    [J]. OBESITY SURGERY, 2015, 25 (07) : 1239 - 1250
  • [5] Portable Sleep Monitoring for Diagnosing Sleep Apnea in Hospitalized Patients With Heart Failure
    Aurora, R. Nisha
    Patil, Susheel P.
    Punjabi, Naresh M.
    [J]. CHEST, 2018, 154 (01) : 91 - 98
  • [6] Practice Parameters for the Surgical Modifications of the Upper Airway for Obstructive Sleep Apnea in Adults
    Aurora, R. Nisha
    Casey, Kenneth R.
    Kristo, David
    Auerbach, Sanford
    Bista, Sabin R.
    Chowdhuri, Susmita
    Karippot, Anoop
    Lamm, Carin
    Ramar, Kannan
    Zak, Rochelle
    Morgenthaler, Timothy I.
    [J]. SLEEP, 2010, 33 (10) : 1408 - 1413
  • [7] Symptoms of Insomnia among Patients with Obstructive Sleep Apnea Before and After Two Years of Positive Airway Pressure Treatment
    Bjornsdottir, Erla
    Janson, Christer
    Sigurdsson, Jon F.
    Gehrman, Philip
    Perlis, Michael
    Juliusson, Sigurdur
    Arnardottir, Erna S.
    Kuna, Samuel T.
    Pack, Allan I.
    Gislason, Thorarinn
    Benediktsdottir, Bryndis
    [J]. SLEEP, 2013, 36 (12) : 1901 - 1909
  • [8] Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial
    Blackman, A.
    Foster, G. D.
    Zammit, G.
    Rosenberg, R.
    Aronne, L.
    Wadden, T.
    Claudius, B.
    Jensen, C. B.
    Mignot, E.
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2016, 40 (08) : 1310 - 1319
  • [9] The impact of sleep disorders on glucose metabolism: endocrine and molecular mechanisms
    Briancon-Marjollet, Anne
    Weiszenstein, Martin
    Henri, Marion
    Thomas, Amandine
    Godin-Ribuot, Diane
    Polak, Jan
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2015, 7
  • [10] SKUP3 randomised controlled trial: polysomnographic results after uvulopalatopharyngoplasty in selected patients with obstructive sleep apnoea
    Browaldh, Nanna
    Nerfeldt, Pia
    Lysdahl, Michael
    Bring, Johan
    Friberg, Danielle
    [J]. THORAX, 2013, 68 (09) : 846 - 853